LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) updated its third quarter 2026 earnings guidance on Tuesday morning. LeMaitre Vascular also updated its FY 2026 guidance to 2.840-2.940 EPS. LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. LeMaitre Vascular Company Profile(Get Free Report)LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Founded in 1983 by George D.Featured StoriesReceive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.